Antiretroviral Therapy Intensification With Dolutegravir and/or Maraviroc Did Not Affect HIV-1 Cell-Associated DNA, RNA, and 2–LTR Circles Over 12 Weeks

By afschroeder • October 28, 2025

Reed JC, Hall L, McKhann A, Kwak G, Goecker EA, Coombs RW, Chen H, Roa J, Vecchio A, Daar ES, Hunt PW, Marra CM, Campbell TB, Ma Q, Swaminathan S, Macatangay BJC, Morse GD, Miller T, Rusin D, Ha B, Alston-Smith B, Paul R, Letendre SL, Spudich SS, Greninger AL. Antiretroviral Therapy Intensification With Dolutegravir and/or Maraviroc Did Not Affect HIV-1 Cell-Associated DNA, RNA, and 2--LTR Circles Over 12 Weeks. Open Forum Infect Dis. 2025 Oct 1;12(10):ofaf594. doi: 10.1093/ofid/ofaf594. PMID: 41141451; PMCID: PMC12548372.

Tags: 2-LTR, ART intensification, ddPCR, dolutegravir, Harbor UCLA, HIV, Infectious Diseases, Maraviroc, Publications, reservoir

Pulmonary Rehabilitation Prolongs Life…And May Be Dying

Mosher CL, Casaburi R. Pulmonary Rehabilitation Prolongs Life…And May Be Dying. Am J Respir Crit Care Med. 2026 Apr 7:aamag168. doi: 10.1093/ajrccm/aamag168. Epub ahead of[...]

Association of Polygenic Risk Scores With Aortic Valve Calcium: The Multi-Ethnic Study of Atherosclerosis

Whelton SP, Yao J, Clish C, Wood AC, Taylor KD, Blaha MJ, Budoff M, Marrero N, Thanassoulis G, Post WS, Guo X, Rotter JI. Association[...]

Plaque, P-Values, and Presentation Bias: Four Limitations of the EKSTROM Trial

Budoff MJ, Verghese D, Kinninger A, Lakshmanan S. Plaque, P-Values, and Presentation Bias: Four Limitations of the EKSTROM Trial. Eur Heart J Cardiovasc Imaging. 2026[...]